David Stark, executive vice president and chief legal officer of financially strapped Teva Pharmaceutical Industries, said he feels like he can breathe easier for the first time in years thanks to a new CEO who is working to bring stability to the company.

Stark has been with Israel-based Teva, the world’s largest generic drug manufacturer, since 2002. “And it’s been a fairly wild ride,” he said in a recent interview with Corporate Counsel.